BREAKING
KVH Industries Inc (KVHI) Reports Q4 Earnings 2 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 2 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 2 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 2 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 3 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 3 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 3 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 3 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 4 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 4 hours ago KVH Industries Inc (KVHI) Reports Q4 Earnings 2 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 2 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 2 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 2 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 3 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 3 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 3 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 3 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 4 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 4 hours ago
MRNA

Moderna, Inc

$MRNA NASDAQ May 4, 2022 BMO Q1 2022

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

MRNA Coverage

Transcript Moderna, Inc (MRNA) Q4 2025 Earnings Call Transcript Mar 10, 2026 News BioNTech (BNTX) Posts Q4 Loss of $-1.25/Share as Revenue Falls 23.8% YoY to $907.4M Mar 10, 2026 Event Moderna, Inc (MRNA) Sec Form 8K Mar 6, 2026 Event Moderna, Inc (MRNA) Moderna Resolves Global Patent Litigation with Arbutus/Genevant Mar 3, 2026 Event Moderna, Inc (MRNA) European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19 Feb 27, 2026 News Moderna Q4 2025 net loss narrows; revenue drops 30% Feb 16, 2026 News Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth Feb 13, 2026 Transcript Moderna, Inc (MRNA) Q2 2022 Earnings Call Transcript Jan 27, 2026